Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2023 Global Healthcare Conference on Wednesday, September 13th at 8:30 – 9:00...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced the pricing of its offering of $435,000,000 in aggregate principal amount of its 1.75% Convertible Senior Notes due 2028 (the...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced its intention to offer, subject to market and other conditions, $435,000,000 in aggregate principal amount of Convertible...

Envista Holdings Corporation (NYSE: NVST) today announced results for the second quarter 2023. For the quarter ended June 30, 2023, reported sales increased 2.6% to $662.4 million. Core sales...

As part of its mission to provide access to oral care around the world, the Envista Smile Project completed its second mission trip to the Dominican Republic, where volunteers treated a...

Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its second quarter 2023 on Wednesday, August 2, 2023. Envista will discuss these results on a conference...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Stifel 2023 Jaws & Paws Conference on Wednesday, May 31, 2023, from 8:00 – 8:30 AM EDT...

Envista Holdings Corporation (NYSE: NVST) today announced results for the first quarter 2023. For the quarter ended March 31, 2023, reported sales decreased 0.7% to $627.2 million. Core sales...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Bank of America Health Care Conference in Las Vegas on Tuesday, May 9, 2023, from...

Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its first quarter 2023 on Wednesday, May 3, 2023. Envista will discuss these results on a conference call on...

Envista Holdings Corporation (NYSE: NVST) recently announced that the company will be hosting its third annual Envista Summit in North America February 15-17, 2024, in Anaheim, California....

As part of its commitment to expanding and improving access to oral health for those in need, Envista Holdings Corporation (NYSE: NVST) ("Envista") announced today that the Envista Smile Project...

Envista Holdings Corporation (NYSE: NVST) today announced results for the fourth quarter 2022 and fiscal year 2022. As previously disclosed, on December 31, 2021, we completed the sale of the KaVo...

Envista Holdings Corporation (NYSE: NVST) today announced that the company will be holding an Investor Access Event at its Envista Summit on Friday, February 24th from 8:00 am – 10:00 am PT....

Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2022 on Wednesday, February 8, 2023. Envista will discuss these results on a conference...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 from 3:00...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate virtually in the Evercore ISI 5th Annual HEALTHCONx Conference on Wednesday, November 30,...

Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter 2022. As previously disclosed, on December 31, 2021, we completed the sale of the KaVo Treatment Unit and...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Jefferies London Healthcare Conference on Thursday, November 17, 2022, from 9:45 –...

Envista Holdings Corporation (NYSE: NVST) today announced the release of its 2021 Sustainability Report, highlighting the Company's progress and approach to embedding environmental, social, and...

Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2022 on Thursday, November 3, 2022. Envista will discuss these results on a conference...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Piper Sandler MedTech and Diagnostics California Bus Tour on Wednesday, August 24,...

Envista Holdings Corporation (NYSE: NVST) today announced results for the second quarter 2022. As previously disclosed, on December 31, 2021, we completed the sale of the KaVo Treatment Unit and...

Envista Holdings Corporation ("Envista") announced today an extension and expansion of their commercial partnership with dentalcorp Holdings Ltd., Canada's largest DSO, network of dental...

Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its second quarter 2022 on Wednesday, August 3, 2022. Envista will discuss these results on a conference...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Stifel 2022 Jaws & Paws Conference on Wednesday, June 1, 2022, from 9:45 – 10:15 AM EST...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced it has entered into a definitive agreement to acquire Osteogenics Biomedical Inc, Allotech LLC and OBI Biologics, Inc...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in William Blair Emerging Technologies in Dental Care Virtual Conference on Tuesday, May...

Envista Holdings Corporation (NYSE: NVST) today announced results for the first quarter 2022. As previously disclosed, on December 31, 2021, we completed the sale of the KaVo Treatment Unit and...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced the completion of the acquisition of Carestream Dental's Intraoral Scanner business. As previously announced, this business...

Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its first quarter 2022 on Wednesday, May 4, 2022. Envista will discuss these results on a conference call on...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced Envista's KaVo imaging business will be re-branded as "DEXIS". Dental professionals have known the DEXIS brand as the leader...

Envista Holdings Corporation (NYSE: NVST) ("Envista") -- Envista announced today the 510(k) Food and Drug Administration (FDA) clearance of its Assisted Intelligence (AI) mandibular nerve tracing...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Piper Sandler Dental Day on Tuesday, March 29th from 7:00 – 7:45 AM PT. Investors will...

Envista Holdings Corporation (NYSE: NVST) today announced that the company will be holding an Investor Day at its Envista Summit on Friday, April 1st from 8:00 am – 10:30 am CT. Interested...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Jefferies Virtual Dental Summit on Thursday, February 24th from 6:00 – 6:45 AM PST....

In the news release, Envista Reports Fourth Quarter 2021 Earnings, issued 09-Feb-2022 by Envista Holdings Corporation over PR Newswire, we are advised by the company that the third paragraph in...

Envista Holdings Corporation (NYSE: NVST) announced that it has renewed its partnership agreement with the Vitaldent Group, a leading Spanish Dental Service Organization (DSO). Vitaldent is...

Envista Holdings Corporation (NYSE: NVST) ("Envista") -- and leading dental support organization Pacific Dental Services® (PDS) announced today the extension of their implant and imaging...

Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2021 on Wednesday, February 9, 2022. Envista will discuss these results on a conference...

Envista Holdings Corporation (NYSE: NVST) ("Envista") -- Envista and leading dental support organization Pacific Dental Services® (PDS) announce today the consummation of a multi-year year...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that it closed the previously disclosed divestiture of its KaVo Treatment Unit & Instrument business. Envista received $317.3...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the U.S. Food and Drug Administration (FDA) has cleared the Nobel Biocare N1™ implant system. Boasting a biologically...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced an update to the company's participation at the 40th Annual J.P. Morgan Healthcare Conference. Envista will present virtually...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced it has entered into a definitive agreement to acquire Carestream Dental's Intra-Oral Scanner (IOS) business for $600 million....

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the following upcoming investor conferences: Stifel MedTech Madness 2021 Annual West...

Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter 2021. As previously disclosed, in September we reached an agreement to sell our KaVo Treatment Unit and...

Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2021 on Wednesday, November 3, 2021. Envista will discuss these results on a conference...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced it entered into a binding agreement to sell its KaVo Treatment Unit and Instrument business to planmeca Verwaltungs GmbH...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird Global Healthcare Virtual Conference on Tuesday, September 14, 2021 at 2:35 PM...